Sanggenol L was reported to sensitize NSCLC cells to ferroptosis by upregulating miR-26a-1-3p, which silenced the expression of the E3 ubiquitin ligase MDM2, resulting in the downregulation of p53-mediated SLC7A11 protein expression [59]. Here, MDM2 is linked to non-small cell lung carcinoma.